A niosome formulation modulates the Th1/Th2 bias immune response in mice and also provides protection against anthrax spore challenge

References

• InglesbyTVO’TooleTHendersonDAAnthrax as a biological weapon, 2002: updated recommendations for managementJAMA2002287172236225211980524
   PubMed Web of Science ®Google Scholar
• FriedlanderAMWelkosSLPittMLPostexposure prophylaxis against experimental inhalation anthraxJ Infect Dis19931675123912428486963
   PubMed Web of Science ®Google Scholar
• KaurMBhatnagarRRecent progress in the development of anthrax vaccinesRecent Pat Biotechnol20115314815922360464
   PubMedGoogle Scholar
• Flick-SmithHCWalkerNJGibsonPA recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infectionInfect Immun20027031653165611854261
   PubMed Web of Science ®Google Scholar
• ScobieHMRaineyGJBradleyKAYoungJAHuman capillary morphogenesis protein 2 functions as an anthrax toxin receptorProc Natl Acad Sci U S A200310095170517412700348
   PubMed Web of Science ®Google Scholar
• BradleyKAMogridgeJMourezMCollierRJYoungJAIdentification of the cellular receptor for anthrax toxinNature2001414686022522911700562
   PubMed Web of Science ®Google Scholar
• MogridgeJCunninghamKLacyDBMourezMCollierRJThe lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigenProc Natl Acad Sci U S A200299107045704811997437
   PubMed Web of Science ®Google Scholar
• KintzerAFThorenKLSterlingHJThe protective antigen component of anthrax toxin forms functional octameric complexesJ Mol Biol2009392361462919627991
   PubMed Web of Science ®Google Scholar
• MilneJCFurlongDHannaPCWallJSCollierRJAnthrax protective antigen forms oligomers during intoxication of mammalian cellsJ Biol Chem19942693220607206128051159
   PubMed Web of Science ®Google Scholar
• MogridgeJCunninghamKCollierRJStoichiometry of anthrax toxin complexesBiochemistry20024131079108211790132
   PubMed Web of Science ®Google Scholar
• CunninghamKLacyDBMogridgeJCollierRJMapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigenProc Natl Acad Sci U S A200299107049705311997439
   PubMed Web of Science ®Google Scholar
• AbramiLLindsayMPartonRGLepplaSHvan der GootFGMembrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathwayJ Cell Biol2004166564565115337774
   PubMed Web of Science ®Google Scholar
• KlimpelKRAroraNLepplaSHAnthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activityMol Microbiol1994136109311007854123
   PubMed Web of Science ®Google Scholar
• DuesberyNSWebbCPLepplaSHProteolytic inactivation of MAP-kinase-kinase by anthrax lethal factorScience199828053647347379563949
   PubMed Web of Science ®Google Scholar
• VitaleGBernardiLNapolitaniGMichèleMMontecuccoCSusceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factorBiochemical Journal2000352373974511104681
   PubMedGoogle Scholar
• VitaleGPellizzariRRecchiCNapolitaniGMockMMontecuccoCAnthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophagesBiochem Biophys Res Commun199824837067119703991
   PubMed Web of Science ®Google Scholar
• LepplaSHAnthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cellsProc Natl Acad Sci U S A19827910316231666285339
   PubMed Web of Science ®Google Scholar
• BozzutoGMolinariALiposomes as nanomedical devicesInt J Nanomedicine20151097525678787
   PubMed Web of Science ®Google Scholar
• HuntCATsangSα-Tocopherol retards autoxidation and prolongs the shelf-life of liposomesInt J Pharm198182101110
   Web of Science ®Google Scholar
• WongMThompsonTEAggregation of dipalmitoylphosphatidyl-choline vesiclesBiochemistry19822117413341396896999
   PubMed Web of Science ®Google Scholar
• BaillieAJFlorenceATHumeLRMuirheadGTRogersonAThe preparation and properties of niosomes – non-ionic surfactant vesiclesJ Pharm Pharmacol198537128638682868092
   PubMed Web of Science ®Google Scholar
• UchegbuIFFlorenceATNonionic surfactant vesicles (niosomes): physical and pharmaceutical chemistryAdv Colloid Interface Sci1995581155
   Web of Science ®Google Scholar
• KumarGPRajeshwarraoPNonionic surfactant vesicular systems for effective drug delivery – an overviewActa Pharm Sin B201114208219
   Web of Science ®Google Scholar
• BrewerJMAlexanderJThe adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albuminImmunology19927545701592432
   PubMed Web of Science ®Google Scholar
• ManishMRahiAKaurMBhatnagarRSinghSA single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challengePLoS One201384e6188523637922
   PubMed Web of Science ®Google Scholar
• MoghassemiSHadjizadehAOmidfarKFormulation and characterization of bovine serum albumin-loaded niosomeAAPS PharmSciTech2017181273326817764
   PubMed Web of Science ®Google Scholar
• TournierJNRossi PaccaniSQuesnel-HellmannABaldariCTAnthrax toxins: a weapon to systematically dismantle the host immune defensesMol Aspects Med200930645646619560486
   PubMed Web of Science ®Google Scholar
• BrennemanKEDoganayMAkmalAThe early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthraxFEMS Immunol Med Microbiol201162216417221401726
   PubMedGoogle Scholar
• MerkelTJPereraPYKellyVKDevelopment of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entitiesProc Natl Acad Sci U S A201010742180911809620921397
   PubMed Web of Science ®Google Scholar
• McbrideBWMoggATelferJLProtective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markersVaccine19981688108179627938
   PubMed Web of Science ®Google Scholar
• HughesHRCrillWDChangGJManipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancementVirol J20129111522709350
   PubMedGoogle Scholar
• WelkosSLKeenerTJGibbsPHDifferences in susceptibility of inbred mice to Bacillus anthracisInfect Immun19865137958003081444
   PubMed Web of Science ®Google Scholar
• LindbladEBAluminium compounds for use in vaccinesImmunol Cell Biol200482549750515479435
   PubMed Web of Science ®Google Scholar
• UnwinCBlatchleyNCokerWHealth of UK servicemen who served in Persian Gulf WarLancet199935391481691789923871
   PubMed Web of Science ®Google Scholar
• RibeiroSRijpkemaSGDurraniZFlorenceATPLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in miceInt J Pharm2007331222823217258876
   PubMedGoogle Scholar
• ManayaniDJThomasDDrydenKAA viral nanoparticle with dual function as an anthrax antitoxin and vaccinePLoS Pathog2007310e142
   PubMed Web of Science ®Google Scholar
• KachuraMAHickleCKellSAA CpG-Ficoll nanoparticle adjuvant for anthrax protective antigen enhances immunogenicity and provides single-immunization protection against inhaled anthrax in monkeysJ Immunol2016196128429726608924
   PubMed Web of Science ®Google Scholar
• SzokaFPapahadjopoulosDProcedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporationProc Natl Acad Sci U S A197875941944198279908
   PubMed Web of Science ®Google Scholar
• KambojSSainiVBalaSSharmaGFormulation and characterization of drug loaded niosomal gel for anti-inflammatory activityInt Sch Sci Res Innov201320137541545
   Google Scholar
• BielinskaAUJanczakKWLandersJJMucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challengeInfect Immun20077584020402917502384
   PubMed Web of Science ®Google Scholar
• CoteCKRossiCAKangASMorrowPRLeeJSWelkosSLThe detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactionsMicrob Pathog2005385–620922515925272
   PubMed Web of Science ®Google Scholar
• LondoñoDMarquesAHornungRLCadavidDIL-10 helps control pathogen load during high-level bacteremiaJ Immunol200818132076208318641346
   PubMed Web of Science ®Google Scholar
• DobrovolskaiaMAMcneilSEImmunological properties of engineered nanomaterialsNat Nanotechnol20072846947818654343
   PubMed Web of Science ®Google Scholar
• LunovOSyrovetsTLoosCDifferential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell lineACS Nano2011531657166921344890
   PubMed Web of Science ®Google Scholar
• RehmBSchuelerDSmall, smaller, smallestKreysaGMarquardtRBiotechnology 2020: From the Transparent Cell to the Custom-Designed ProcessBrusselsEuropean Commission Directorate-General for Research20055863
   Google Scholar